Abstract: A pool cover assembly includes a first encapsulation member defining a first side of a pool cover encapsulation, the first encapsulation member comprising a first mating feature. The pool cover assembly further includes a second encapsulation member defining a second side of the pool cover encapsulation, the second encapsulation member comprising a second mating feature. And the pool cover assembly further includes a corner endcap member comprising a third mating feature and a fourth mating feature. The first encapsulation member is coupleable to the corner endcap by the first mating feature and the third mating feature, and the second encapsulation member is coupleable to the corner endcap by the second mating feature and the fourth mating feature. The corner endcap member couples with the first encapsulation member and the second encapsulation member to form a corner of the pool cover encapsulation.

Abstract: The present disclosure relates to isolated non-naturally occurring delivery constructs comprising a bacterial toxin-derived delivery construct coupled to a biologically active therapeutic cargo; wherein the delivery construct is capable of delivering the biologically active cargo via transcytosis transport across an epithelial cell; and wherein the delivery construct does not comprise a bacterial toxin-derived translocation domain or a bacterial toxin-derived catalytic (cytotoxic) domain.

Abstract: This document describes methods by which an autonomous vehicle deploys a simulation scenario while operating in a real-world environment. The vehicle's sensors collect perception data. During a run of the vehicle in a real-world environment, the vehicle's on-board computing system will: (i) receive the perception data; (ii) publish the perception data to a muxing tool of the on-board computing system; (iii) generate simulation data that identifies and labels one or more simulated objects in the environment; (iv) publish the simulation data to the muxing tool; (v) use the muxing tool to add at least a portion of the simulation data to the perception data to yield augmented perception data; and (v) use at least a portion of the augmented perception data to make one or more navigation decisions based for the autonomous vehicle.

Abstract: A system of creating a simulation scenario definition to simulate behavior of an autonomous vehicle includes a computing device and a computer-readable storage medium having one or more programming instructions. The system identifies an event on which a simulation scenario definition is to be based, identifies one or more log files associated with the event, parses the one or more log files in a time-sequential order and populates the simulation scenario definition with information from the identified log files until an event trigger is detected, identifies an actor from one or more of the log files, infer a shape of the actor, generates one or more simulated tracks that includes the inferred shape for the actor, and adds the simulated tracks to the simulation scenario definition.

Abstract: Methods and systems for allowing for incremental updates to remote localized copies of disk images (e.g., virtual machine images) are described. In some implementations, the disk images are block-based. The incremental updates may be done in a bi-directional manner across different platforms such that an update to any platform may be prepared for any of the other platforms. Preparation of updates between platforms may be accomplished through one or more of combining disk images, differencing disk images, snapshotting disk images, and/or versioning disk images.

Abstract: A method in a first wireless communication device for displaying current location information representing a current location of a second wireless communication device. The method entails, from within a communication application executing on a processor of the first wireless communication device, receiving the current location information representing the current location of the second wireless communication device, performing a reverse look-up of the received current location of the second wireless communication device to determine address information, displaying a map from within the communication application, and identifying the received current location information on the displayed map with a name associated with the determined address information.

Abstract: This document discloses system, method, and computer program product embodiments for operating an autonomous vehicle (AV). For example, the method includes performing the following operations by a muxing tool when AV is deployed within a particular geographic area in a real-world environment: receiving perception data that is representative of at least one actual object which is perceived while AV is deployed within the particular geographic area in a real-world environment; receiving simulation data that represents a simulated object that could be perceived by AV in the real-world environment and that was generated using a simulation scenario which is selected from a plurality of simulation scenarios based on at least one of the particular geographic area in which AV is currently located and a current operational state of AV; and generating augmented perception data by combining the simulation data with the perception data.

Abstract: Method and systems for generating vehicle motion planning model simulation scenarios are disclosed. The system receives a base simulation scenario with features of a scene through which a vehicle may travel. The system then generates an augmentation element with a simulated behavior for an object in the scene by: (i) accessing a data store in which behavior probabilities are mapped to object types to retrieve a set of behavior probabilities for the object; and (ii) applying a randomization function to the behavior probabilities to select the simulated behavior for the object. The system will add the augmentation element to the base simulation scenario at the interaction zone to yield an augmented simulation scenario. The system will then apply the augmented simulation scenario to an autonomous vehicle motion planning model to train the motion planning model.

Abstract: Method and systems for generating vehicle motion planning model simulation scenarios are disclosed. The method receives a base simulation scenario with features of a scene through which a vehicle may travel, defines an interaction zone in the scene, generates an augmentation element that includes an object and a behavior for the object, and adds the augmentation element to the base simulation scenario at the interaction zone to yield an augmented simulation scenario. The augmented simulation scenario is applied to a vehicle motion planning model to train the model.

Abstract: A pool cover assembly includes a first encapsulation member defining a first side of a pool cover encapsulation, the first encapsulation member comprising a first mating feature. The pool cover assembly further includes a second encapsulation member defining a second side of the pool cover encapsulation, the second encapsulation member comprising a second mating feature. And the pool cover assembly further includes a corner endcap member comprising a third mating feature and a fourth mating feature. The first encapsulation member is coupleable to the corner endcap by the first mating feature and the third mating feature, and the second encapsulation member is coupleable to the corner endcap by the second mating feature and the fourth mating feature. The corner endcap member couples with the first encapsulation member and the second encapsulation member to form a corner of the pool cover encapsulation.

Abstract: The present disclosure provides delivery constructs comprising a carrier coupled to a heterologous payload, wherein coupling of the carrier to the payload can result in transportation of the payload (e.g., a therapeutic payload) into and/or across intact polarized epithelial cells (e.g., epithelial cells of the gut of a mammal). The delivery construct can be part of a pharmaceutical composition that can be orally administered to a subject to provide for improved, effective therapies for treatment of, e.g., inflammatory diseases or autoimmune diseases.

Abstract: A refrigerator includes a refrigerator cabinet, a fresh food compartment disposed within the cabinet, a freezer compartment disposed within the cabinet, an ice compartment disposed within the cabinet, and an electronic control system associated with the refrigerator and adapted to monitor and control the fresh food compartment, the freezer compartment and the ice compartment. The control system provides for energy efficient control and operation through various means, including by monitoring state of an ice maker associated with the ice compartment and controlling temperature within compartments of the refrigerator based on the ice maker state. A damper controls air flow between the fresh food and freezer compartments. The control system can direct heat to the damper if the damper becomes frozen.

Abstract: Systems and methods for map quality assurance and/or vehicle control. The methods comprise: generating, by the computing device, a plurality of simulation routes for a vehicle to traverse in a map; simulating, by the computing device, operations of the vehicle along each route of the plurality of simulation routes in the map; analyzing, by the computing device, results from the simulating to validate whether or not a quality of the map is validated; causing, by the computing device, the map to be used to control autonomous or semi-autonomous operations of the vehicle, when a determination is made that the quality of the map is validated; and performing a given operation other than said causing, when a determination is made that the quality of the map is not validated.

Abstract: A pool cover assembly includes a first encapsulation member defining a first side of a pool cover encapsulation, the first encapsulation member comprising a first mating feature. The pool cover assembly further includes a second encapsulation member defining a second side of the pool cover encapsulation, the second encapsulation member comprising a second mating feature. And the pool cover assembly further includes a corner endcap member comprising a third mating feature and a fourth mating feature. The first encapsulation member is coupleable to the corner endcap by the first mating feature and the third mating feature, and the second encapsulation member is coupleable to the corner endcap by the second mating feature and the fourth mating feature. The corner endcap member couples with the first encapsulation member and the second encapsulation member to form a corner of the pool cover encapsulation.

Abstract: The present disclosure provides complexes and compositions comprising particles, microparticles or nanoparticles, for delivery of payloads into a cell or across a polarized epithelial cell. The compositions can comprise a payload in a pill or tablet for delivery of the payload into or across a polarized epithelial cell.

Abstract: A system of creating a simulation to simulate behavior of an autonomous vehicle includes a simulation system having an electronic device and a computer-readable storage medium having one or more programming instructions. When executed, the one or more programming instructions cause the electronic device to identify an event that is to be analyzed, receive from an autonomous vehicle system a first data stream that includes event information from one or more vehicle event log files that corresponds to the event, receive from a vehicle dynamics model a second data stream that includes synthetic event information that corresponds to the event, until a switch point is detected operate in a pure log execution stage, upon detection of the switch point operate in a play-forward execution stage, and cause the new simulation to be executed.

Abstract: The present disclosure relates to isolated non-naturally occurring delivery constructs comprising a bacterial toxin-derived delivery construct coupled to a biologically active therapeutic cargo; wherein the delivery construct is capable of delivering the biologically active cargo via transcytosis transport across an epithelial cell; and wherein the delivery construct does not comprise a bacterial toxin-derived translocation domain or a bacterial toxin-derived catalytic (cytotoxic) domain.

Abstract: A pressure gauge includes a housing, a helical tube, and a compensation member. The housing has an inlet. The helical tube is arranged within the housing and has a closed end and an open end, the open end of the helical tube in fluid communication with the inlet. The compensation member is arranged between the between the open end and the closed end of the helical tube, the compensation member fixed to the helical tube. The compensation member and the helical tube are formed from materials having different coefficients of thermal expansion to limit movement of the closed end of the helical tube due to temperature change of a compressed fluid in fluid communication with the helical tube. Pressure vessel assemblies and methods of displaying pressure in pressure vessels are also described.

Abstract: A discharge valve includes a valve body, a closure, and a non-rigid valve member. The valve body has a bore that extends between an inlet and an outlet. The closure is seated to the valve body and extends to the bore. The non-rigid valve member has an interior and is fixed within the bore between the inlet and the outlet of the valve, the interior of the non-rigid valve member in fluid communication with the closure for expansion and contraction of the non-rigid valve member. Fire extinguisher assemblies and methods of making fire extinguisher assemblies are also described.

Abstract: The present disclosure provides delivery constructs comprising a carrier coupled to a heterologous payload, wherein coupling of the carrier to the payload can result in transportation of the payload (e.g., a therapeutic payload) into and/or across intact polarized epithelial cells (e.g., epithelial cells of the gut of a mammal). The delivery construct can be part of a pharmaceutical composition that can be orally administered to a subject to provide for improved, effective therapies for treatment of, e.g., inflammatory diseases or autoimmune diseases.